The global dacryocystitis market is projected to grow at a significant CAGR during the forecast period. Dacryocystitis is an in?ammation of the lacrimal sac and duct. It may be congenital or acquired. Acquired dacryocystitis assumes two main forms including acute and chronic. The primary factors that drive the growth of the market include increased prevalence of eye infections and increasing clinical research along with novel product launches. Additionally, it is also a crucial cause of ocular morbidity, both in children and adults. Hence, it requires special attention concerning the initiation of the appropriate treatment at the earliest.
Get Free Sample link @ https://www.omrglobal.com/request-sample/dacryocystitis-market
Further, as per the studies by IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), chronic dacryocystitis is more common than acute dacryocystitis but also has several stages of presentation like epiphora, mucoid discharge, conjunctival hyperemia, and chronic conjunctivitis. Thus, the seriousness regarding the treatment of such eye-related disorders is likely to create scope for market growth during the forecast period.
A full report of Global Dacryocystitis Market available @ https://www.omrglobal.com/industry-reports/dacryocystitis-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Dacryocystitis Market by Indication
- Acute
- Chronic
- Others (Congenital)
Regional Analysis
- North America
- United States
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Akorn, Inc.
- Alembic Pharmaceuticals Ltd.
- Aurobindo Pharma Ltd.
- Bess Medizintechnik GmbH
- Cigna
- Cipla Ltd.
- Eyevance Pharmaceuticals
- Gunther Weiss Scientific Glass Co. Inc.
- FCI Ophthalmics
- GlaxoSmithKline Plc
- Kaneka Corp.
- LABIANA GROUP
- Merck & Co. Inc.
- Mylan NV
- Nosch
- Novartis International AG
- Orex Pharma Pvt. Ltd.
- Perrigo Co.
- Pfizer Inc.
- PRODECO PHARMA Srl
- Rexall Pharmacy Group Ltd. (McKesson Corp.)
- Teligent, Inc.
The Report Covers
- Market value data analysis of 2019 and forecast to 2026.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global dacryocystitis market. Based on the availability of data, information related to products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/dacryocystitis-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
